Categories: HospitalsNews

ProxsysRx earns URAC Accreditation for specialty pharmacy services

BIRMINGHAM, Ala., July 25, 2024 /PRNewswire/ — The ProxsysRx specialty pharmacy team, led by VP Heather Brooks and Compliance & Accreditation Manager Lauren Robinson, has earned accreditation status from URAC — the medical profession’s gold standard for third-party validation of high-quality health care.

ProxsysRx is just the fourth company awarded the highly coveted status, and the only company offering health systems a comprehensive range of consultative and hands-on pharmacy-related support services.

“We could not be more thrilled by this honor, particularly given the backbreaking effort required to meet URAC’s standards,” said ProxsysRx founder and CEO George Salem. “Accreditation represents a genuine, empirical milestone in ProxsysRx’s ability to guide and support hospitals seeking to build, own and manage successful specialty pharmacies.”

“The single greatest benefit URAC’s validation offers the hospitals we serve is a significant reduction in the calendar time, and in the personnel time-investment, required to earn the accreditation they need to own a successful specialty pharmacy,” explained Brooks. “For all practical purposes, our accreditation cuts a hospital’s specialty pharmacy accreditation time frame — typically 12 months — in half.”

While URAC does not publicly share its accreditation standards, the six-month validation process places, under the proverbial microscope, every aspect (and every member), of an applicant organization’s specialty pharmacy-services operation — from Clinical Patient Management and Quality Management to the security measures in place to protect all patient and pharmacy information.

“URAC even maintains standards for call center service,” Brooks continues. “A specialty pharmacy is expected to answer all calls within 30 seconds, with a ‘call abandonment’ rate of under five percent. And every effort undertaken in a specialty pharmacy requires reporting, in trackable metrics, to document that its processes and services are meeting URAC standards.”

To make the challenge even more daunting, URAC only awards full accreditation status to organizations meeting all mandatory measures and scoring 94% or higher in its validation testing.

About ProxsysRx
ProxsysRx offers hospital systems proven solutions for optimizing pharmacy services’ positive impact on the continuum of care; solutions ranging from comprehensive 340B prescription-program management and retail pharmacy operations to PBM program management and patient financial assistance. ProxsysRx’s services are available on an integrated-program basis — or in individual components — and are supported by the company’s proprietary software system, which places actionable data, and business intelligence, at clients’ fingertips, in real time.

Contact:
Michael Jones
205-706-2586 | mtjones1105@gmail.com

View original content:https://www.prnewswire.com/news-releases/proxsysrx-earns-urac-accreditation-for-specialty-pharmacy-services-302206777.html

SOURCE ProxsysRx

Staff

Recent Posts

Best Testosterone Supplement For Men Over 40 and 50: Testo Prime for Muscle Growth & Libido 2025

If you are male and in your 40's and 50's and feel your testosterone levels…

19 minutes ago

The Anxiety Clinic Launches Innovative Approach to Transform Anxiety into Positive Energy

Transforming Anxiety into Positive Energy: A New Approach by The Anxiety ClinicBondi Junction, New South…

4 hours ago

Solace Psychology Announces Expanded Holiday Stress Management and Mental Health Support Services

Embracing Mental Well-Being During the Festive SeasonCarlton North, Australia--(Newsfile Corp. - December 24, 2024) -…

6 hours ago

Strong Natural Diet Pill Over the Counter for 2025 – PhenQ OTC Weight Loss Supplement

If you are researching the strongest over the counter weight loss supplements in 2025 -…

6 hours ago

Fortitude Wellbeing Enhances Mental Health Services with Comprehensive ADHD Assessments

Fortitude Wellbeing Expands Offerings with ADHD AssessmentsSouth Yarra, Australia--(Newsfile Corp. - December 24, 2024) -…

8 hours ago

MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today…

9 hours ago